Phathom Pharmaceuticals (PHAT) Equity Ratio: 2022-2025
Historic Equity Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -1.76.
- Phathom Pharmaceuticals' Equity Ratio fell 263.74% to -1.76 in Q3 2025 from the same period last year, while for Sep 2025 it was -1.76, marking a year-over-year decrease of 263.74%. This contributed to the annual value of -0.67 for FY2024, which is 281.25% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Equity Ratio stood at -1.76, which was down 8.42% from -1.62 recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Equity Ratio registered a high of 0.26 during Q1 2022, and its lowest value of -1.76 during Q3 2025.
- In the last 3 years, Phathom Pharmaceuticals' Equity Ratio had a median value of -0.63 in 2023 and averaged -0.69.
- Per our database at Business Quant, Phathom Pharmaceuticals' Equity Ratio spiked by 302.54% in 2023 and then tumbled by 1,202.54% in 2024.
- Quarterly analysis of 4 years shows Phathom Pharmaceuticals' Equity Ratio stood at -0.45 in 2022, then spiked by 61.27% to -0.18 in 2023, then tumbled by 281.25% to -0.67 in 2024, then slumped by 263.74% to -1.76 in 2025.
- Its last three reported values are -1.76 in Q3 2025, -1.62 for Q2 2025, and -1.15 during Q1 2025.